Active Biotech Future Growth
Future criteria checks 0/6
Active Biotech is forecast to grow earnings and revenue by 59.7% and 75.2% per annum respectively.
Key information
59.7%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 36.7% |
| Revenue growth rate | 75.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Feb 2024 |
Recent future growth updates
Recent updates
Is Active Biotech (STO:ACTI) In A Good Position To Invest In Growth?
Feb 19
Active Biotech (STO:ACTI) Will Have To Spend Its Cash Wisely
Jul 27Here's Why Active Biotech (STO:ACTI) Must Use Its Cash Wisely
May 07Here's Why We're Not Too Worried About Active Biotech's (STO:ACTI) Cash Burn Situation
Nov 09We're Hopeful That Active Biotech (STO:ACTI) Will Use Its Cash Wisely
May 03We're Keeping An Eye On Active Biotech's (STO:ACTI) Cash Burn Rate
Jan 18
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 28 | -2 | N/A | -2 | 1 |
| 12/31/2025 | 36 | -15 | N/A | -15 | 1 |
| 12/31/2024 | N/A | -43 | N/A | -43 | 1 |
| 12/31/2023 | N/A | -46 | -46 | -46 | N/A |
| 9/30/2023 | N/A | -48 | -48 | -48 | N/A |
| 6/30/2023 | N/A | -51 | -50 | -50 | N/A |
| 3/31/2023 | N/A | -54 | -51 | -51 | N/A |
| 12/31/2022 | N/A | -58 | -55 | -55 | N/A |
| 9/30/2022 | N/A | -60 | -57 | -57 | N/A |
| 6/30/2022 | N/A | -57 | -55 | -55 | N/A |
| 3/31/2022 | N/A | -56 | -53 | -53 | N/A |
| 12/31/2021 | N/A | -50 | -46 | -46 | N/A |
| 9/30/2021 | 6 | -38 | -35 | -35 | N/A |
| 6/30/2021 | 6 | -35 | -33 | -33 | N/A |
| 3/31/2021 | 6 | -32 | -29 | -29 | N/A |
| 12/31/2020 | 7 | -32 | -32 | -32 | N/A |
| 9/30/2020 | 1 | -39 | -38 | -38 | N/A |
| 6/30/2020 | 2 | -40 | -37 | -37 | N/A |
| 3/31/2020 | 3 | -36 | -40 | -40 | N/A |
| 12/31/2019 | 8 | -34 | -36 | -36 | N/A |
| 9/30/2019 | 12 | -32 | -35 | -35 | N/A |
| 6/30/2019 | 16 | -31 | -37 | -37 | N/A |
| 3/31/2019 | 21 | -35 | -38 | -38 | N/A |
| 12/31/2018 | 20 | -37 | -41 | -41 | N/A |
| 9/30/2018 | 21 | -88 | -41 | -41 | N/A |
| 6/30/2018 | 21 | -88 | -43 | -43 | N/A |
| 3/31/2018 | 20 | -103 | -44 | -44 | N/A |
| 12/31/2017 | 20 | -109 | -46 | -46 | N/A |
| 9/30/2017 | 22 | -63 | N/A | -52 | N/A |
| 6/30/2017 | 21 | -67 | N/A | -57 | N/A |
| 3/31/2017 | 20 | -59 | N/A | -61 | N/A |
| 12/31/2016 | 19 | -60 | N/A | -73 | N/A |
| 9/30/2016 | 17 | -86 | N/A | -86 | N/A |
| 6/30/2016 | 18 | -97 | N/A | -123 | N/A |
| 3/31/2016 | 17 | -152 | N/A | -187 | N/A |
| 12/31/2015 | 16 | -194 | N/A | -218 | N/A |
| 9/30/2015 | 14 | -210 | N/A | -245 | N/A |
| 6/30/2015 | 12 | -243 | N/A | -256 | N/A |
| 3/31/2015 | 11 | -229 | N/A | -243 | N/A |
| 12/31/2014 | 10 | -232 | N/A | -267 | N/A |
| 9/30/2014 | 12 | -257 | N/A | -157 | N/A |
| 6/30/2014 | 116 | -171 | N/A | -159 | N/A |
| 3/31/2014 | 116 | -194 | N/A | -170 | N/A |
| 12/31/2013 | 116 | -212 | N/A | -102 | N/A |
| 9/30/2013 | 203 | -130 | N/A | -248 | N/A |
| 6/30/2013 | 136 | -211 | N/A | -256 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACTI is forecast to have no revenue next year.
High Growth Revenue: ACTI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACTI's Return on Equity is forecast to be high in 3 years time